Literature DB >> 22583724

Chemical leukoderma after the application of a transdermal methylphenidate patch.

Pedram Ghasri, Shilpa Gattu, Naz Saedi, Anand K Ganesan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22583724      PMCID： PMC3354955          DOI： 10.1016/j.jaad.2011.03.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Daytrana: the first year.

Authors:  Elisa F Cascade; Amir H Kalali; David Feifel
Journal:  Psychiatry (Edgmont)       Date:  2007-10

2.  A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder.

Authors:  Robert L Findling; Alain Katic; Richard Rubin; Eliot Moon; Richard Civil; Yunfeng Li
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-10       Impact factor: 2.576

3.  Common pigmentation disorders.

Authors:  Scott Plensdorf; Joy Martinez
Journal:  Am Fam Physician       Date:  2009-01-15       Impact factor: 3.292
  3 in total
  2 in total

Review 1.  Chemical-Induced Vitiligo.

Authors:  John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

2.  Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Carmen Cheng; Lois La Grenade; Ida-Lina Diak; Allen Brinker; Robert L Levin
Journal:  J Pediatr       Date:  2016-10-10       Impact factor: 4.406
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.